Erin Kelley
Nurse Practitioner · Orange, CANPI 1639408040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $976 and has fallen 89.6% since, to $101 in 2023.
Across 87 payments — averaging $22.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$222
- Eisai Inc.$181
- Seagen Inc.$130
- AbbVie$127
- EMD Serono, Inc.$99
- Bayer$83
- plus $1K from 28 others
What the payments were for
- Food & beverage$1,989100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 11 | $222 |
| Eisai Inc. | 9 | $181 |
| Seagen Inc. | 5 | $130 |
| AbbVie | 6 | $127 |
| EMD Serono, Inc. | 4 | $99 |
| Bayer | 4 | $83 |
| GSK | 3 | $73 |
| Octapharma USA, Inc. | 2 | $73 |
| Blueprint Medicines Corporation | 3 | $72 |
| Amgen | 3 | $72 |
| Incyte Corporation | 3 | $66 |
| Pfizer | 2 | $61 |
| Boehringer Ingelheim | 3 | $60 |
| Johnson & Johnson | 2 | $55 |
| CSL Behring | 2 | $50 |
| Merck | 2 | $45 |
| Deciphera Pharmaceuticals Inc. | 2 | $43 |
| AstraZeneca | 2 | $40 |
| Taiho Oncology, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $39 |
| Foundation Medicine, Inc. | 2 | $37 |
| Tersera Therapeutics LLC | 1 | $34 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| AMAG Pharmaceuticals, Inc. | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $24 |
| Medtronic | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Novartis | 1 | $19 |
| Sanofi | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $16 |
How this compares
$1,989 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Orange
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.